Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Kathrin Dellas"'
Autor:
Charlotte Pfaffendorf, Reinhard Vonthein, Katja Krockenberger-Ziegler, Kathrin Dellas, Andreas Schreiber, Dorit Uhlemann, Stefan Dinges, Florian Würschmidt, Peter Andreas, Evelyn Weinstrauch, Kirsten Eilf, Dirk Rades, Ulrike Höller, Stephanie E. Combs, Renata Kazmierczak, Fabian Fehlauer, Ulrike Schreck, Jörg Zimmer, Jürgen Dunst, David Krug
Publikováno v:
Breast, Vol 64, Iss , Pp 136-142 (2022)
Purpose: To analyze long-term results of two multicenter prospective single-arm trials (ARO-2010-01 and ARO-2013-04) investigating adjuvant hypofractionated radiotherapy (HF) with simultaneous integrated boost (SIB) after breast-conserving surgery (B
Externí odkaz:
https://doaj.org/article/d300223b219549cebd4511bb1cc231f4
Autor:
David Krug, Reinhard Vonthein, Alicia Illen, Denise Olbrich, Jörg Barkhausen, Julia Richter, Wolfram Klapper, Claudia Schmalz, Achim Rody, Nicolai Maass, Dirk Bauerschlag, Nicole Heßler, Inke R. König, Kathrin Dellas, Jürgen Dunst
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 28, Iss , Pp 90-96 (2021)
Background: Several recent randomized therapeutic exploratory trials demonstrated improvement of progression-free survival and in some even overall survival using stereotactic body radiotherapy in patients with oligometastatic disease. However, only
Externí odkaz:
https://doaj.org/article/3a04d72d708f49a1a6613e2cf6c0ba24
Autor:
Ping Jiang, Katja Krockenberger, Reinhard Vonthein, Jane Tereszczuk, Arne Schreiber, Sebastian Liebau, Stefan Huttenlocher, Detlef Imhoff, Panagiotis Balermpas, Christian Keller, Kathrin Dellas, Rene Baumann, Claus Rödel, Guido Hildebrandt, Klaus-Peter Jünemann, Alex S. Merseburger, Alan Katz, Andreas Ziegler, Oliver Blanck, Jürgen Dunst
Publikováno v:
Radiation Oncology, Vol 12, Iss 1, Pp 1-7 (2017)
Abstract Background For prostate cancer treatment, treatment options with minimal side effects are desired. External beam radiation therapy (EBRT) is non-invasive, standard of care and delivered in either conventional fractionation over 8 weeks or wi
Externí odkaz:
https://doaj.org/article/29d8937f6a9c477488540540d3582dac
Autor:
Achim Rody, A Illen, Dirk Bauerschlag, Julia Richter, Nicolai Maass, Claudia Schmalz, Wolfram Klapper, Denise Olbrich, Jörg Barkhausen, Inke R. König, Kathrin Dellas, Nicole Heßler, Reinhard Vonthein, David Krug, Jürgen Dunst
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 28, Iss, Pp 90-96 (2021)
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology
Highlights • Local ablative radiotherapy is associated with high rates of local control. • Prognosis in oligometastatic disease may be improved by metastases-directed therapy. • OLIGOMA assesses the role of radiotherapy in oligometastatic breas
Autor:
J Zimmer, R. Schneider, Denise Olbrich, Nicole Heßler, Inke R. König, Reinhard Vonthein, Reinhold Laubach, Alexander D. Boicev, A Illen, S. Dinges, Kathrin Dellas, Evelyn Weinstrauch, Thomas Martin, David Krug, Jürgen Dunst, Andreas Schreiber, Matthias Hipp, N. Weidner, Juliane Hörner-Rieber
Publikováno v:
Strahlentherapie Und Onkologie
Purpose Hypofractionated radiotherapy is the standard of care for adjuvant whole breast radiotherapy (RT). However, adoption has been slow. The indication for regional nodal irradiation has been expanded to include patients with 0–3 involved lymph
Autor:
Oliver Blanck, Kathrin Dellas, David Krug, Florian Pyschny, Jürgen Dunst, Nicolai Maass, Alexander Fabian
Publikováno v:
Der Gynäkologe. 52:918-926
Die Behandlung von Mammakarzinompatientinnen hat sich v. a. durch Neuentwicklungen im Bereich der Systemtherapie enorm verbessert, sodass ein mehrjahriges Uberleben fur viele Patientinnen erreichbar ist. Neuere Erkenntnisse im Bereich der Tumorbiolog
Autor:
Inke R. König, Reinhard Vonthein, R Laubach, Andreas Schreiber, R Schneider, S. Dinges, E Weinstrauch, Kathrin Dellas, J Zimmer, Thorsten Heilmann, M van Mackelenbergh, N. Weidner, Nicolai Maass, Denise Olbrich, Mohamed Elessawy, Achim Rody, Juergen Dunst, Thomas Martin, D Krug, AD Boicev, Matthias Hipp, A Illen
Publikováno v:
Geburtshilfe und Frauenheilkunde.
Autor:
Peter Andreas, Ulrike Höller, David Krug, S. Dinges, Reinhard Vonthein, Kirsten Eilf, J Zimmer, Karen Piefel, Andreas Schreiber, Jürgen Dunst, Katja Krockenberger, Kathrin Dellas, Alexander D. Boicev, Evelyn Weinstrauch, Florian Würschmidt, René Baumann
Publikováno v:
Strahlentherapie Und Onkologie
Purpose We report results of a multicenter prospective single-arm phase II trial (ARO-2013-04, NCT01948726) of moderately accelerated hypofractionated radiotherapy with a simultaneous integrated boost (SIB) in patients with breast cancer receiving ad
Autor:
N. Weidner, S. Dinges, Nicolai Maass, Denise Olbrich, E Weinstrauch, Matthias Hipp, Achim Rody, Andreas Schreiber, Juergen Dunst, A Illen, J Zimmer, Mohamed Elessawy, R Schneider, R Laubach, M van Mackelenbergh, Thorsten Heilmann, Thomas Martin, D Krug, AD Boicev, Inke R. König, Reinhard Vonthein, Kathrin Dellas
Publikováno v:
Senologie - Zeitschrift für Mammadiagnostik und -therapie.
Autor:
Kathrin Dellas, Jürgen Dunst, Andreas Schreiber, Frank Sieker, Thomas Kuhnt, A. Pirnasch, Peter Hass, Rita Engenhart-Cabillic, Michael Richter, Matthias G. Hautmann
Publikováno v:
Strahlentherapie und Onkologie. 193:733-741
Cetuximab (CET) is a potent inhibitor of the epidermal growth factor receptor and has been shown to have activity in squamous cell carcinoma of the head and neck (SCCHN). We conducted a single-arm phase II trial of a combination therapy comprising ci